Clinical trial of transcatheter arterial chemoembolization combined with lanreotide and celecoxib in the treatment for hepatocellular carcinoma
Phase of Trial: Phase IV
Latest Information Update: 23 Apr 2016
At a glance
- Drugs Celecoxib (Primary) ; Lanreotide (Primary) ; Antineoplastics
- Indications Liver cancer
- Focus Therapeutic Use
- 22 Aug 2012 Planned number of patients changed from 100 to 130 as reported by Chinese Clinical Trial Register record (ChiCTR-TRC08000191).
- 30 Nov 2011 ChiCTR-TRC-08000191 reports trial status as recruiting.
- 02 May 2011 New trial record